Klindamicin hameln 150 mg/ml otopina za injekciju / infuziju
| Name | Klindamicin hameln 150 mg/ml otopina za injekciju / infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-115926948 |
| Active Substance | klindamicinfosfat |
| Composition | svaki ml otopine sadrži klindamicinfosfat koji odgovara 150 mg klindamicina |
| Pharmaceutical Form | Otopina za injekciju / infuziju |
| Manufacturer | hameln rds, Modra, Slovačka
Siegfried Hameln GmbH, Hameln, Njemačka |
| Marketing Authorisation Holder | hameln pharma gmbh, Inselstrasse 1, Hameln, Njemačka |
| Marketing Authorisation Date | 06.05.2021 |
| MA Period of Validity | 06.05.2026 |
| Classification Number | UP/I-530-09/19-01/102 |
| Registration Number | 381-12-01/70-21-04 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | J01FF01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
